Rapid Fire 1

Moderator

Supriya Koya, University of Alabama at Birmingham, Birmingham, AL

Presentation numberRF1-01

Postoperative Complication Rates of Minimally Invasive Mastectomy Compared to Conventional Mastectomy: A Prospective Multicenter Cohort Study (MARRES)

Hyung Seok Park, Yonsei University College of Medicine, Seoul, Korea, Republic of

Presentation numberRF1-02

Surgical outcomesin the ALTERNATE trial (Alliance A011106) -a randomized phase 3 neoadjuvant endocrine therapy (NET) trial in postmenopausal women with clinical stage II/III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC)

Ann Marilyn Leitch, UT Southwestern Medical Center, Dallas, TX

Presentation numberRF1-03

Magnetic resonance imaging based internal mammary node response after neoadjuvant therapy to guide postoperative internal mammary node boost radiotherapy in breast cancer

Yushuo Peng, Peking University Cancer Hospital and Institute, Beijing, China

Presentation numberRF1-04

Early Adverse Symptoms Predict Response to Treatment Among Patients in the I-SPY Trial

Amrita Basu, University of California San Francisco, San Francisco, CA

Presentation numberRF1-05

Utilization of ePROs and smart pill bottles to improve adherence to adjuvant endocrine therapy in early-stage breast cancer

Steven A Manobianco, Sidney Kimmel Comprehensive Cancer Center – Jefferson Health, Philadelphia, PA

Presentation numberRF1-06

Discordance in End-of-Life Decision-Making: A Quantitative Study on the Values and Preferences of Japanese Cancer Patients and Their Family Members

Akihiko Ozaki, Jyoban Hospital of Tokiwa Foundation, Iwaki, Japan

Presentation numberRF1-07

Cruciferous vegetable intake, dietary glucosinolate and risk of breast cancer in 2 large prospective studies

Andrea Romanos-Nanclares, Brigham and Women's Hospital and Harvard Medical School, Boston, MA